XML 47 R16.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Collaboration Revenue | 3 Months Ended
--- | ---
Mar. 31, 2015
Collaboration Revenue |
Collaboration Revenue | 10.Collaboration Revenue In January 2014, the Company announced the initiation of a Phase 1 clinical program in its spinal muscular atrophy collaboration with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc. (Roche) and the Spinal Muscular Atrophy Foundation which triggered a $7.5 million milestone payment from Roche. The Company considered this milestone event substantive because the applicable criteria of its revenue recognition policy would be satisfied and recorded it as collaboration revenue for the three months ended March 31, 2014.

X
- Details
Name: | ptct_CollaborationRevenuesDisclosureAbstract
Namespace Prefix: | ptct_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the entire disclosure pertaining to collaboration revenue. + References No definition available. + Details
Name: | ptct_CollaborationRevenuesDisclosureTextBlock
Namespace Prefix: | ptct_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration